Research article · 30 Jun 2016
CommentaryPublished 16 Feb 2012
Anthrax Bioterrorism and Current Vaccines
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Bacillus anthracis a Category A agent with the potential to be used in a large-scale bioterrorism attack. The current vaccine, known as Anthrax Vaccine Adsorbed (AVA), consists of a culture filtrate from an attenuated strain adsorbed to aluminum salts as an adjuvant. Although considered to be safe and effective, it is difficult to produce large amounts within a short time frame. Thus, there exists a need to produce a new-generation vaccine against anthrax that can be produced quickly. In order for the new candidate vaccines to be effective, they must elicit a high titer of antibodies against protective antigen (PA). PA neutralization minimizes host susceptibility to anthrax toxemia. In addition, eliciting antibodies against additional virulence factors, such as capsule antigens of B. anthracis, may enhance clearance of pathogen from host. This review will discuss the history of bioterrorism and current vaccine development against anthrax. To date, there have been advances in vaccine design that utilize manipulated spores, modified protein subunits, conjugated vaccines and viral delivery vehicles. Utilizing one or more of these advances may provide a new, better vaccine against anthrax.
Subjects
Vaccines & ImmunisationAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 15 Oct 2013
Development of edible vaccine against anthrax by using edema factor gene of Bacillus anthracis
Conference abstract · 20 Feb 2017
Conjugate rPA-PGA anthrax vaccine induces protective antibodies
Review article · 23 Apr 2011
Anthrax Bioterrorism: Prevention, Diagnosis and Management Strategies
Conference abstract
Development of DNA vaccine against anthrax, botulism and smallpox with dual vector system
More from this journal
The newest in Journal of Bioterrorism & Biodefense.
Editorial · 10 Dec 2025
Advanced Biodefense: Detection, Prevention, Preparednes
Case report · 10 Dec 2025
CRISPR: Enhancing Plant Resistance for Sustainability
Editorial · 10 Dec 2025
Adaptive Global Biodefense Against Future Threats
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Bioterrorism & Biodefense
- SubjectVaccines & Immunisation
- BylineArticles whose byline prints “Shan Chen”
- BylineArticles whose byline prints “Mingtao Zeng”
